Goodwin: Absci Closes $86.4M Follow-On Offering
March 06, 2024
March 06, 2024
BOSTON, Massachusetts, March 6 -- Goodwin, a law firm, issued the following news release on March 4, 2023:
The Life Sciences team advised Absci Corporation (Nasdaq: ABSI) on the closing of its underwritten public offering of 19,205,000 shares of its common stock at a public offering price of $4.50 per share, before deducting underwriting discounts and commissions. The shares of common stock include 2,505,000 shares pursuant to the option granted by Absci to the underwriters, which w . . .
The Life Sciences team advised Absci Corporation (Nasdaq: ABSI) on the closing of its underwritten public offering of 19,205,000 shares of its common stock at a public offering price of $4.50 per share, before deducting underwriting discounts and commissions. The shares of common stock include 2,505,000 shares pursuant to the option granted by Absci to the underwriters, which w . . .